Ionis Pharmaceuticals Inc (IONS)
33.94
-1.46
(-4.11%)
USD |
NASDAQ |
Nov 21, 16:00
33.94
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Gross Profit Margin (Quarterly): 99.20% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 99.20% |
| June 30, 2024 | 98.15% |
| March 31, 2024 | 98.20% |
| December 31, 2023 | 99.06% |
| September 30, 2023 | 98.48% |
| June 30, 2023 | 98.65% |
| March 31, 2023 | 98.97% |
| December 31, 2022 | 97.57% |
| September 30, 2022 | 99.05% |
| June 30, 2022 | 96.45% |
| March 31, 2022 | 97.06% |
| December 31, 2021 | 99.49% |
| September 30, 2021 | 97.69% |
| June 30, 2021 | 97.65% |
| March 31, 2021 | 97.69% |
| December 31, 2020 | 98.86% |
| September 30, 2020 | 98.07% |
| June 30, 2020 | 97.93% |
| March 31, 2020 | 98.09% |
| December 31, 2019 | 99.80% |
| September 30, 2019 | 99.42% |
| June 30, 2019 | 99.17% |
| March 31, 2019 | 99.65% |
| December 31, 2018 | 99.05% |
| September 30, 2018 |
| Date | Value |
|---|---|
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
96.45%
Minimum
Jun 2022
99.80%
Maximum
Dec 2019
98.31%
Average
98.18%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biogen Inc | 74.10% |
| Alnylam Pharmaceuticals Inc | 82.85% |
| Biomarin Pharmaceutical Inc | 74.73% |
| Amicus Therapeutics Inc | 90.62% |
| Arbutus Biopharma Corp | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -93.21% |
| Return on Assets | -12.41% |
| Return on Invested Capital | -21.57% |
| Profit Margin (Quarterly) | -105.0% |
| Operating Margin (Quarterly) | -111.1% |
| Return on Net Operating Assets | -108.6% |